A biomarker-enriched, randomized phase II trial of Adavosertib (AZD1775) plus Paclitaxel and Carboplatin for women with Platinum-sensitive TP53-mutant Ovarian Cancer
by Oza, Amit M. (Author)
, Estevez-Diz, Maria (Author)
, Grischke, Eva-Maria (Author)
, Hall, Marcia (Author)
, Marmé, Frederik (Author)
, Provencher, Diane (Author)
, Uyar, Denise (Author)
, Weberpals, Johanne I. (Author)
, Wenham, Robert M. (Author)
, Laing, Naomi (Author)
, Tracy, Michael (Author)
, Freshwater, Tomoko (Author)
, Lee, Mark A. (Author)
, Liu, Ji (Author)
, Qiu, Jingjun (Author)
, Rose, Shelonitda (Author)
, Rubin, Eric H. (Author)
, Moore, Kathleen (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource